On December 7, the Indian Pharmacopoeia Commission (IPC) issued a drug safety alert about the commonly used painkiller Meftal, saying that its constituent, mefenamic acid, triggers severe allergic ...

Those who rely on Meftal spas to alleviate pain, menstrual cramps or rheumatoid arthritis then this news is for you. The Indian Pharmacopoeia Commission (IPC) has issued a drug safety alert ...

Meftal is a commonly used painkiller that has been known to provide quick relief for menstrual cramps, headaches and more such issues. Pharma standard body Indian Pharmacopoeia Commission (IPC ...

Government has issued alert about an adverse reaction of Meftal. The syndrome causes a diverse array of symptoms, from 2 to 8 weeks after initiating the drug. The Indian Pharmacopoeia Commission ...

The Indian Pharmacopoeia Commission (IPC) on Thursday issued an alert regarding the common painkiller, Meftal, and said that people must take the drug only after consulting a doctor as it contains ...

As per a preliminary analysis conducted by the Pharmacovigilance Programme of India (PvPI), this drug reacts with eosinophilia and systemic symptoms (DRESS) syndrome. Meftal spas is a readily ...

The oral dose for adults is 325 to 650 mg every 4 to 6 hours. The maximum daily dose is 4 grams. Child- the recommended dose is 10 to 15 mg/kg every 4 to 6 hours. Caution should be exercised in ...